We provide a suite of services supporting therapeutic protein/antibody/ADC discovery, development and IND filing. Our featured services are epitope mapping, bioanalysis and analytical characterization.
NovaBioAssays uses advanced liquid chromatographic assays (LC-MS/MS, LC-HRMS, LC-fluorescence) and ligand-binding assays (Hybridization ELISA) to quantify and characterize oligonucleotide therapeutics in biological matrices.
Using triple quadrupole and high-resolution mass spec, NovaBioAssays provides bioanalysis services for small molecule drug/metabolite and various biomarkers including lipids, amino acids, neurotransmitters, etc.
We develop high sensitivity analytical methods for bioanalysis and characterization to support clients with gene therapy technology.